Toward Kidney-Specific Causality Assessment Tool

Kaya M., Duru M., Gulmez S. E.

CLINICAL THERAPEUTICS, cilt.44, sa.7, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 44 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.clinthera.2022.05.008
  • Dergi Adı: CLINICAL THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: causality assessment tool, DIAKI, drug-induced acute kidney injury, drug safety, pharmacovigilance, pharmacoepidemiology, ADVERSE DRUG-REACTIONS, OPERATIONAL ASSESSMENT, FRENCH METHOD, ALGORITHM, INJURY, PHARMACOVIGILANCE, VALIDATION, RISK, PHARMACOGENOVIGILANCE, REPRODUCIBILITY
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose: Current nonspecific causality assessment tools lack the assessment of drug-induced acute kidney injury (DIAKI). We recently published an editorial letter for developing a specific causality assessment tool for DIAKI. The purpose of the present review was to suggest the possible required parameters and outline the path to developing a kidney-specific causality assessment tool (KSCAT).